Clinical Trial Update: Disrupted Sleep, Neuroendocrine Status and the Behavioral Symptoms of AD [NA]

View source ↗

Summary

Johns Hopkins University completed a clinical trial investigating disrupted sleep, neuroendocrine status, and behavioral symptoms in Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Johns Hopkins University | Conditions: Alzheimer's Disease | NA | Status: COMPLETED